E-LIB Suche - Ergebnisse für: Puglisi, F

1

211P Drug-drug interactions and their impact on clinical ou..:

Botticelli, A. ; Arpino, G. ; Bianchini, G....
ESMO Open. 9 (2024) - p. 103233 , 2024

Link: https://doi.org/10.1016/..

2

Efficacy of adjuvant chemotherapy schedules for breast canc..:

Poggio, F. ; Blondeaux, E. ; Tagliamento, M....
ESMO Open. 9 (2024) 8 - p. 103650 , 2024

Link: https://doi.org/10.1016/..

3

158TiP Neoadjuvant abemaciclib and giredestrant trial in pa..:

von Arx, C. ; Calabrese, A. ; Caputo, R....
ESMO Open. 9 (2024) - p. 103145 , 2024

Link: https://doi.org/10.1016/..

4

Intermediate clinical endpoints in early-stage breast cance..:

Blondeaux, E. ; Xie, W. ; Carmisciano, L....
European Journal of Cancer. 200 (2024) - p. 113607 , 2024

Link: https://doi.org/10.1016/..

5

154P Validation of PREDICT tool version 2.2 in early-stage ..:

Borea, R. ; Blondeaux, E. ; Carmisciano, L....
ESMO Open. 9 (2024) - p. 103141 , 2024

Link: https://doi.org/10.1016/..

6

210P Prognostic value of HER2-low status in metastatic brea..:

Molinelli, C. ; Bruzzone, M. ; Blondeaux, E....
ESMO Open. 9 (2024) - p. 103232 , 2024

Link: https://doi.org/10.1016/..

7

Second-line treatment strategies for RAS wild-type colorect..:

Di Nardo, P. ; Basile, D. ; Siciliano, A....
Digestive and Liver Disease. 56 (2024) 5 - p. 786-794 , 2024

Link: https://doi.org/10.1016/..

8

229P The influence of ethnicity on cyclin-dependent kinase ..:

Buonaiuto, R. ; Caltavituro, A. ; Pagliuca, M....
ESMO Open. 9 (2024) - p. 103251 , 2024

Link: https://doi.org/10.1016/..

9

Adjuvant endocrine therapy choices in premenopausal patient..:

Arecco, L. ; Latocca, M.M. ; Blondeaux, E....
European Journal of Cancer. 200 (2024) - p. 113698 , 2024

Link: https://doi.org/10.1016/..

10

209P Trastuzumab plus lapatinib or chemotherapy in patients..:

De Angelis, C. ; Pagliuca, M. ; Gamucci, T....
ESMO Open. 8 (2023) 1 - p. 101398 , 2023

Link: https://doi.org/10.1016/..

11

Corrigendum to "Optimizing choices and sequences in the dia..:

Miglietta, F. ; Fabi, A. ; Generali, D....
Cancer Treatment Reviews. 117 (2023) - p. 102570 , 2023

Link: https://doi.org/10.1016/..

12

Corrigendum to "Optimizing choices and sequences in the dia..:

Miglietta, F. ; Fabi, A. ; Generali, D....
Cancer Treatment Reviews. 119 (2023) - p. 102594 , 2023

Link: https://doi.org/10.1016/..

13

Optimizing choices and sequences in the diagnostic-therapeu..:

Miglietta, F. ; Fabi, A. ; Generali, D....
Cancer Treatment Reviews. 114 (2023) - p. 102511 , 2023

Link: https://doi.org/10.1016/..

14

199P Correlation of circulating tumor DNA (ctDNA) or thymid..:

Arpino, G. ; Bianchini, G. ; Malorni, L....
ESMO Open. 8 (2023) 1 - p. 101388 , 2023

Link: https://doi.org/10.1016/..

15

Discontinuation rate and serious adverse events of chemoimm..:

Rizzo, A. ; Schipilliti, F.M. ; Di Costanzo, F....
ESMO Open. 8 (2023) 6 - p. 102198 , 2023

Link: https://doi.org/10.1016/..